Currently, several epidemiological studies have focus on the association between inflammatory markers and the risk of MCI in T2D patients [11, 12], which showed that hs-CRP or IL-6 were found to be associated with the risk of MCI among T2D patients. The gene discussed is IL6; the disease is type 2 diabetes mellitus.